TFPI and endothelial dysfunction: Sustained inflammatory activation of endothelial cells can result in endothelial dysfunction (8) marked by exposure of tissue factor, aberrant release of Von Willebrand factor multimers, and decreased production of endogenous anticoagulants such as tissue factor pathway inhibitor (TFPI) and antithrombin (44).